Enriqueta Felip, MD, PhD

Enriqueta Felip, MD, PhD, discusses key efficacy data from the MARIPOSA trial and its implications.

Enriqueta Felip, MD, PhD, discusses EGFR-mutated non-small cell lung cancer and how to approach it from multiple angles.

Enriqueta Felip, MD, PhD, medical oncologist, Vall d'Hebron University Hospital, Barcelona, Spain, discusses the efficacy and safety of ceritinib in patients with ALK-positive non-small cell lung cancer (NSCLC).